INS and diabetes mellitus: J-15 presented with extremely low pre-treatment insulin levels (14 μU/mL), significant hyperglycemia (275 mg/dL, fed glucose) and low body weight (<10 kg at study intake) representative of a more advanced stage of diabetes disease as compared to 5 other monkeys in the main cohort.